Table 2 Comparison of neurotrophic factors and oxidative stress parameters with the healthy control and patient groups (Control: Healthy Control & Patient: pre-rTMS).
Variables | Control (n = 25) | Patient (n = 26) | p | |
---|---|---|---|---|
BDNF ng/mL | mean ± SD | 8.02 ± 1.11 | 3.68 ± 0.9 | <0.01*a |
S100B ng/L | 100.76 ± 20.25 | 194.8 ± 22.47 | <0.01*a | |
ALLO pg/mL | 1195.26 ± 158.42 | 694.34 ± 81.54 | <0.01*a | |
TAS mmol ascorbate Eq./L | 0.99 ± 0.12 | 0.72 ± 0.11 | <0.01*a | |
OSI AU | 10.79 ± 3.01 | 20.5 ± 5.01 | <0.01*a | |
NT μM | 422.68 ± 46.72 | 275.13 ± 78.5 | <0.01*a | |
DIS μM | 51.68 ± 33.32 | 79.89 ± 43.19 | <0.01*a | |
GDNF pg/mL | mean (min-max) | 416.01 (385.75–618.91) | 217.08 (154.75–250.03) | <0.01*b |
TOS μmol H2O2 Eq./L | 10.08 (6.8–16.53) | 14.68 (10.43–18.48) | <0.01*b | |
TT μM | 516.62 (446.21–635.02) | 429.17 (371.24–582.69) | <0.01*b |